Clinical Trials Browser

Neoplasm, Residual × Drug Therapy × Lymphoid × Clear all

NCT03367299 2025-01-22

LAL2317

Phase 2 Completed

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma